Immix Biopharma, Inc. ( IMMX) - Stock Earnings
IMMX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.6 million USD | — USD |
| 2025Q4 | -10.7 million USD | — USD |
| 2026Q1 | -10.1 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IMMX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15.4 million USD | — USD |
| 2024 | -21.6 million USD | — USD |
| 2025 | -29.4 million USD | — USD |
| 2026 Est. | — | — |
IMMX
Price: $8.73
52 week price:
Earnings Per Share: -0.92 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 12035
Market Capitalization: 562.4 million